The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial serves as a pillar in our understanding of antidepressant efficacy. It stands as the most extensive and long-term study on treatment-resistant depression, yielding insights on managing patients who show no initial treatment response. In this article, we will examine the significant learnings from this pioneering trial. […]